Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2004-08-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.0404739101PMID 15326293PMCID PMC516468
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of complement and Fc receptors in the pathogenesis of HIV-1 infection

  2004cited by this paper
• HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha.

  2004cited by this paper
• Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection.

  2004cited by this paper
• HIV-1–specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-γ and tumor necrosis factor–α

  2004cited by this paper
• Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication.

  2004cited by this paper
• Use of CD134 As a Primary Receptor by the Feline Immunodeficiency Virus

  2004cited by this paper
• Prospects for an AIDS vaccine: three big questions, no easy answers.

  2004cited by this paper
• AIDS Vaccine Still Alive as Booster After Second Failure in Thailand

  2003cited by this paper
• Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever

  2003cited by this paper
• Disappointing Data Scuttle Plans for Large-Scale AIDS Vaccine Trial

  2002cited by this paper
• AIDS vaccine models: Challenging challenge viruses

  2002cited by this paper
• The dual role of CD4 T helper cells in the infection dynamics of HIV and their importance for vaccination.

  2002cited by this paper
• AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Failure To Protect and Possible Enhancement of Challenge Infection by Four Cell-Based Vaccines Prepared with Autologous Lymphoblasts

  2002cited by this paper
• HIV preferentially infects HIV-specific CD4+ T cells

  2002cited by this paper
• Lymphoid activation: a confounding factor in AIDS vaccine development?

  2002cited by this paper
• Visualization and quantification of T cell–mediated cytotoxicity using cell-permeable fluorogenic caspase substrates

  2002cited by this paper
• Safety and Immunogenicity of a High‐Titered Canarypox Vaccine in Combination With rgp120 in a Diverse Population of HIV‐1‐Uninfected Adults: AIDS Vaccine Evaluation Group Protocol 022A

  2002cited by this paper
• Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine

  2001cited by this paper
• Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications.

  2001cited by this paper
• Differential Dynamics of CD4+ and CD8+ T-Lymphocyte Proliferation and Activation in Acute Simian Immunodeficiency Virus Infection

  2000cited by this paper
• Containment of Simian Immunodeficiency Virus Infection: Cellular Immune Responses and Protection from Rechallenge following Transient Postinoculation Antiretroviral Treatment

  2000cited by this paper
• Immune-mediated disease pathogenesis in respiratory syncytial virus infection.

  2000cited by this paper
• Comparative Efficacy of Recombinant Modified Vaccinia Virus Ankara Expressing Simian Immunodeficiency Virus (SIV) Gag-Pol and/or Env in Macaques Challenged with Pathogenic SIV

  2000cited by this paper
• Varicella vaccination: Evidence for frequent reactivation of the vaccine strain in healthy children

  2000cited by this paper
• Intrinsic Susceptibility of Rhesus Macaque Peripheral CD4+ T Cells to Simian Immunodeficiency Virus In Vitro Is Predictive of In Vivo Viral Replication

  2000cited by this paper
• Normal T-Cell Turnover in Sooty Mangabeys Harboring Active Simian Immunodeficiency Virus Infection

  2000cited by this paper
• Recombinant Modified Vaccinia Virus Ankara Expressing the Surface gp120 of Simian Immunodeficiency Virus (SIV) Primes for a Rapid Neutralizing Antibody Response to SIV Infection in Macaques

  2000cited by this paper
• In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.

  1999cited by this paper
• A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.

  1999cited by this paper
• Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1 while Participating in Trials of Recombinant gp120 Subunit Vaccines

  1998cited by this paper
• Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group.

  1998cited by this paper
• A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3

  1997cited by this paper
• Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope

  1997cited by this paper
• A long-term prospective study of varicella vaccine in healthy children.

  1997cited by this paper
• Varicella in chimpanzees

  1996cited by this paper
• Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara

  1996cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines

  1995cited by this paper
• Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement

  1995cited by this paper
• Studies of Complement-Activating Antibodies in the SIV/Macaque Model of Acute Primary Infection and Vaccine Protection

  1995cited by this paper
• Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope

  1994cited by this paper
• Potential pitfalls on the road to an effective HIV vaccine.

  1994cited by this paper
• Arthrite-encephalite caprine: Essai d'une preparation vaccinale adjuvee—I. Etude clinique et virologique

  1993cited by this paper
• [Caprine arthritis-encephalitis: trial of an adjuvant vaccine preparation. I. Clinical and virological study].

  1993cited by this paper
• Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro.

  1993cited by this paper
• Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4.

  1991cited by this paper
• Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay

  1988cited by this paper
• Immunogenicity of wild and attenuated varicella‐zoster virus strains in rhesus monkeys

  1984cited by this paper

• A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses

  2023cites this paper
• Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells

  2023cites this paper
• Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development

  2022cites this paper
• HIV T-cell immunogen design and delivery

  2022cites this paper
• A single lentivector DNA based immunization contains a late heterologous SIVmac251 mucosal challenge infection.

  2020cites this paper
• Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine.

  2020cites this paper
• Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids

  2020cites this paper
• CD4+ T Cells Induced by Tuberculosis Subunit Vaccine H1 Can Improve the HIV-1 Env Humoral Response by Intrastructural Help

  2020cites this paper
• Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers

  2019influential citation
• Antibody-Dependent Enhancement of Viral Infections

  2019cites this paper
• Strong TH1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacy

  2019cites this paper
• Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation

  2019cites this paper
• Epidemiological models for the transmission of HIV/AIDS and relevant coinfections

  2018cites this paper
• 1 Applications of the FIV Model to Study HIV 2 Pathogenesis 3

  2018cites this paper
• Fatores associados aos níveis de marcadores inflamatórios em indivíduos com infecção pelo HIV em seguimento ambulatorial

  2018cites this paper
• Applications of the FIV Model to Study HIV Pathogenesis

  2018cites this paper
• Vaccine-induced protection from homologous Tier 2 simian-human immunodeficiency virus challenge in nonhuman primates

  2018cites this paper
• FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge

  2018cites this paper
• Intrastructural help: improving the HIV-1 envelope antibody response induced by virus-like particle vaccines.

  2017cites this paper
• Conserved HIV Epitopes for an Effective HIV Vaccine

  2017cites this paper
• The Comparative Value of Feline Virology Research: Can Findings from the Feline Lentiviral Vaccine Be Translated to Humans?

  2017cites this paper
• Vector Order Determines Protection against Pathogenic Simian Immunodeficiency Virus Infection in a Triple-Component Vaccine by Balancing CD4+ and CD8+ T-Cell Responses

  2017cites this paper
• Novel Concepts for HIV Vaccine Vector Design

  2017influential citation
• HIV Susceptibility of human antigen-specific CD4 T cells in AIDS pathogenesis and vaccine response

  2016cites this paper
• Chapter 20 – AIDS Vaccines

  2016cites this paper
• The T Cell Co-stimulatory Molecule GITR in the Control and Treatment of a Persistent Viral Infection

  2015cites this paper
• Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection

  2015cites this paper
• A critical analysis of the cynomolgus macaque, Macaca fascicularis, as a model to test HIV-1/SIV vaccine efficacy.

  2015cites this paper
• Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection

  2015cites this paper
• Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses

  2015cites this paper
• Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses

  2015cites this paper
• Stochastic model for HIV dynamics in HIV specific helper cells

  2015cites this paper
• TNFRs and Control of Chronic LCMV Infection: Implications for Therapy.

  2015cites this paper
• HIV-Specific CD4 T Cells and Viral Control

  2015cites this paper
• The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers

  2015cites this paper
• Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact

  2015cites this paper
• Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals

  2014cites this paper
• Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy

  2014cites this paper
• Mathematical model for HIV dynamics in HIV-specific helper cells

  2014cites this paper
• The Different Modes of Resistance to AIDS

  2014cites this paper
• Title Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV : outcome depends on IgG dose Permalink

  2014cites this paper
• Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose

  2014influential citation
• The two faces of vaccine-induced immune response: protection or increased risk of HIV infection?!

  2014cites this paper
• Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development

  2014cites this paper
• 'Omics investigations of HIV and SIV pathogenesis and innate immunity.

  2013cites this paper
• Antibody-dependent enhancement and the risk of HIV infection.

  2013cites this paper
• [Analytic and integrative perspectives for HIV vaccine design].

  2013cites this paper
• PrimatesInduced T Cell Responses In Nonhuman Effective TLR Adjuvant for SIV Gag Protein Polyinosinic-Polycytidylic Acid Is the Most

  2013cites this paper
• Mucosal immunology of HIV infection

  2013cites this paper
• Recombinant Varicella-Zoster Virus Vaccines as Platforms for Expression of Foreign Antigens

  2013cites this paper
• Polyinosinic-Polycytidylic Acid Is the Most Effective TLR Adjuvant for SIV Gag Protein–Induced T Cell Responses In Nonhuman Primates

  2013cites this paper
• Nonhuman Primate Models for HIV/AIDS Vaccine Development

  2013cites this paper
• Viral vaccines and vectors – some lessons from cytomegaloviruses

  2012influential citation
• Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study).

  2012cites this paper
• Broad and Cross-Clade CD4+ T-Cell Responses Elicited by a DNA Vaccine Encoding Highly Conserved and Promiscuous HIV-1 M-Group Consensus Peptides

  2012influential citation
• The T-cell response to HIV.

  2012cites this paper
• Viral vaccines and vectors - some lessons from cytomegaloviruses

  2012cites this paper
• Risk of Immunodeficiency Virus Infection May Increase with Vaccine-Induced Immune Response

  2012cites this paper
• Immune Responses Associated to Viral Control

  2012cites this paper
• Experimental Infection of Cynomolgus Macaques (Macaca fascicularis) with Human Varicella-Zoster Virus

  2012influential citation
• Association of Differentiation State of CD4+ T Cells and Disease Progression in HIV-1 Perinatally Infected Children

  2012cites this paper
• How Can HIV-Type-1-Env Immunogenicity Be Improved to Facilitate Antibody-Based Vaccine Development?

  2012cites this paper
• Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection

  2011influential citation
• AIDS vaccines: the unfolding story.

  2011cites this paper
• Quantification of the Relative Importance of CTL, B Cell, NK Cell, and Target Cell Limitation in the Control of Primary SIV-Infection

  2011cites this paper
• The Cytokine Network of Acute HIV Infection: A Promising Target for Vaccines and Therapy to Reduce Viral Set-Point?

  2011cites this paper
• The TRIM5 Gene Modulates Penile Mucosal Acquisition of Simian Immunodeficiency Virus in Rhesus Monkeys

  2011cites this paper
• T Cell Chemo-Vaccination Effects after Repeated Mucosal SHIV Exposures and Oral Pre-Exposure Prophylaxis

  2011cites this paper
• Immunization with Recombinant HLA Classes I and II, HIV-1 gp140, and SIV p27 Elicits Protection against Heterologous SHIV Infection in Rhesus Macaques

  2011cites this paper
• A Duck Enteritis Virus-Vectored Bivalent Live Vaccine Provides Fast and Complete Protection against H5N1 Avian Influenza Virus Infection in Ducks

  2011cites this paper
• HIV-specific CD4 T cells and immune control of viral replication

  2011cites this paper
• The role of CD4+ T cells in Friend virus infection

  2011cites this paper
• HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS.

  2010cites this paper
• TRIM5 Suppresses Cross-Species Transmission of a Primate Immunodeficiency Virus and Selects for Emergence of Resistant Variants in the New Species

  2010cites this paper
• HIV immunopathogenesis: Inhibition of CD4+ T cell activation

  2010cites this paper
• The varicella-zoster virus genome.

  2010cites this paper
• Induction of balance and breadth in the immune response is beneficial for the control of SIVmac239 replication in rhesus monkeys.

  2010cites this paper
• Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens.

  2010cites this paper
• Neutralizing antibodies in SIV control: co-impact with T cells.

  2010cites this paper
• Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats

  2010influential citation
• Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference.

  2010cites this paper
• Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques.

  2010cites this paper
• Evaluation of the immune response and protective effects of rhesus macaques vaccinated with biodegradable nanoparticles carrying gp120 of human immunodeficiency virus.

  2010cites this paper
• Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection

  2009cites this paper
• Innovative approaches to develop prophylactic and therapeutic vaccines against HIV/AIDS.

  2009cites this paper
• X4 Human Immunodeficiency Virus Type 1 gp120 Down-Modulates Expression and Immunogenicity of Codelivered Antigens

  2009cites this paper
• Obstacles to the successful development of an efficacious T cell‐inducing HIV‐1 vaccine

  2009cites this paper
• Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine against Simian Immunodeficiency Virus Challenge in Rhesus Monkeys

  2009cites this paper
• CD8+ Cell Depletion of SHIV89.6P-Infected Macaques Induces CD4+ T Cell Proliferation that Contributes to Increased Viral Loads1

  2009cites this paper
• Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis

  2009influential citation
• Contributes to Increased Viral Loads T Cell Proliferation + Macaques Induces CD 4 Cell Depletion of SHIV 89 . 6 P-Infected + CD 8

  2009cites this paper
• [Theory for prophylactic AIDS vaccine development].

  2009cites this paper
• Susceptibility to Simian Immunodeficiency Virus Ex Vivo Predicts Outcome of a Prime-Boost Vaccine After SIVmac239 Challenge

  2009cites this paper
• Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.

  2009cites this paper
• Impact of Cytotoxic-T-Lymphocyte Memory Induction without Virus-Specific CD4+ T-Cell Help on Control of a Simian Immunodeficiency Virus Challenge in Rhesus Macaques

  2009cites this paper
• Race between Retroviral Spread and CD4+ T-Cell Response Determines the Outcome of Acute Friend Virus Infection

  2009cites this paper
• A model for testing the immunogenicity of simian immunodeficiency virus and simian-human immunodeficiency virus vaccine candidates in mice.

  2009cites this paper
• Blood and Seminal Plasma HIV-1 RNA Levels Among HIV-1-Infected Injecting Drug Users Participating in the AIDSVAX B/E Efficacy Trial in Bangkok, Thailand

  2009cites this paper
• Race between Retroviral Spread and CD4 (cid:1) T-Cell Response Determines the Outcome of Acute Friend Virus Infection (cid:1)

  2009cites this paper
• Anti‐HIV adaptive immunity: determinants for viral persistence

  2008cites this paper